{"id":"https://openalex.org/W2589650577","doi":"https://doi.org/10.1128/aac.02100-16","title":"Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria","display_name":"Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria","publication_year":2017,"publication_date":"2017-02-22","ids":{"openalex":"https://openalex.org/W2589650577","doi":"https://doi.org/10.1128/aac.02100-16","mag":"2589650577","pmid":"https://pubmed.ncbi.nlm.nih.gov/28223393","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5404544"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02100-16","doi":"https://doi.org/10.1128/aac.02100-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02100-16","pdf_url":"https://aac.asm.org/content/aac/61/5/e02100-16.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/61/5/e02100-16.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"C\u00e9dric Charrier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C\u00e9dric Charrier","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109540638","display_name":"Anne\u2010Marie Salisbury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anne-Marie Salisbury","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033052791","display_name":"Victoria J. Savage","orcid":"https://orcid.org/0000-0002-5381-0731","observed_orcids":["https://orcid.org/0000-0002-5381-0731"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria J. Savage","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Duffy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Duffy","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008099635","display_name":"Emmanuel Moyo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emmanuel Moyo","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017128865","display_name":"Nathan Chaffer-Malam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nathan Chaffer-Malam","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002761667","display_name":"Nicola Ooi","orcid":"https://orcid.org/0000-0002-6747-9699","observed_orcids":["https://orcid.org/0000-0002-6747-9699"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Ooi","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001555630","display_name":"Rebecca Newman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rebecca Newman","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110963782","display_name":"Jonathan Cheung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Cheung","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061937704","display_name":"Richard Metzger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Metzger","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087947325","display_name":"David McGarry","orcid":"https://orcid.org/0000-0002-7087-0584","observed_orcids":["https://orcid.org/0000-0002-7087-0584"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David McGarry","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071102623","display_name":"Mark Pichowicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Pichowicz","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075416938","display_name":"Ralph Sigerson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ralph Sigerson","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103151130","display_name":"Ian R. Cooper","orcid":"https://orcid.org/0000-0002-1820-9879","observed_orcids":["https://orcid.org/0000-0002-1820-9879"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ian R. Cooper","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103736525","display_name":"Gary Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gary Nelson","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008753343","display_name":"Hayley S. Butler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hayley S. Butler","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066958601","display_name":"Mark W. Craighead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Craighead","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060407613","display_name":"Andrew J. Ratcliffe","orcid":"https://orcid.org/0000-0002-0267-1559","observed_orcids":["https://orcid.org/0000-0002-0267-1559"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew J. Ratcliffe","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029797926","display_name":"Stuart A. Best","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stuart A. Best","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061198380","display_name":"Neil R. Stokes","orcid":"https://orcid.org/0000-0001-9984-6521","observed_orcids":["https://orcid.org/0000-0001-9984-6521"]},"institutions":[{"id":"https://openalex.org/I4210162142","display_name":"Redx Pharma (United Kingdom)","ror":"https://ror.org/04wysdg63","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210162142"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Neil R. Stokes","raw_affiliation_strings":["Redx Pharma, Alderley Park, Cheshire, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Redx Pharma, Alderley Park, Cheshire, United Kingdom","institution_ids":["https://openalex.org/I4210162142"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210162142"],"apc_list":null,"apc_paid":null,"fwci":2.1432,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.87900505,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"61","issue":"5","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7821999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.7821999788284302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.17659999430179596,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-gyrase-inhibitors","display_name":"DNA gyrase inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/topoisomerase-iv-inhibitors","display_name":"topoisomerase IV inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/multidrug-resistant-bacteria","display_name":"multidrug-resistant bacteria","score":0.9100000262260437},{"id":"https://openalex.org/keywords/acinetobacter-baumannii","display_name":"Acinetobacter baumannii","score":0.9769999980926514},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.9290000200271606},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.8830000162124634},{"id":"https://openalex.org/keywords/fluoroquinolone-resistance","display_name":"fluoroquinolone resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/spontaneous-resistance","display_name":"spontaneous resistance","score":0.4129999876022339},{"id":"https://openalex.org/keywords/herg-inhibition","display_name":"hERG inhibition","score":0.6510000228881836},{"id":"https://openalex.org/keywords/antibacterial-activity","display_name":"antibacterial activity","score":0.47099998593330383},{"id":"https://openalex.org/keywords/obligate-anaerobes","display_name":"obligate anaerobes","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.680233359336853},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.6536722183227539},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5841333270072937},{"id":"https://openalex.org/C3020442560","wikidata":"https://www.wikidata.org/wiki/Q4971815","display_name":"Broad spectrum","level":2,"score":0.5466289520263672},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5096995830535889},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48510491847991943},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4648538827896118},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4067453145980835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3900120258331299},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3760758638381958},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3202945590019226},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.24758589267730713},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16272303462028503},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.1471189558506012},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13431605696678162}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D027101","descriptor_name":"DNA Topoisomerase IV","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D040981","descriptor_name":"Acinetobacter baumannii","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1128/aac.02100-16","doi":"https://doi.org/10.1128/aac.02100-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02100-16","pdf_url":"https://aac.asm.org/content/aac/61/5/e02100-16.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4567664","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5404544","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5404544","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5404544","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:28223393","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28223393","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.gla.ac.uk:141066","doi":null,"is_oa":false,"landing_page_url":"https://eprints.gla.ac.uk/view/journal_volume/Antimicrobial_Agents_and_Chemotherapy.html>,","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Articles"},{"id":"pmh:oai:strathprints.strath.ac.uk:60125","doi":null,"is_oa":true,"landing_page_url":"https://strathprints.strath.ac.uk/view/author/1060018.html>","pdf_url":"https://strathprints.strath.ac.uk/60125/1/Charrier_etal_AAC_2017_Novel_bacterial_topoisomerase_inhibitors_with_potent_broad_spectrum_activity.pdf","source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1128/aac.02100-16","doi":"https://doi.org/10.1128/aac.02100-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.02100-16","pdf_url":"https://aac.asm.org/content/aac/61/5/e02100-16.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1073258374","display_name":null,"funder_award_id":"FP7/20072013","funder_id":"https://openalex.org/F4320314178","funder_display_name":"European Federation of Pharmaceutical Industries and Associations"},{"id":"https://openalex.org/G1719725309","display_name":null,"funder_award_id":"HHSN272201100009I","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G280512946","display_name":null,"funder_award_id":"HHSN272201100009C","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2973790809","display_name":null,"funder_award_id":"FP7/2007-2013","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3207356259","display_name":null,"funder_award_id":"2007\u20132013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G3559644275","display_name":null,"funder_award_id":"115583","funder_id":"https://openalex.org/F4320314178","funder_display_name":"European Federation of Pharmaceutical Industries and Associations"},{"id":"https://openalex.org/G393177772","display_name":null,"funder_award_id":"FP7 2007-2013","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G470996448","display_name":"European Gram Negative Antibacterial Engine","funder_award_id":"115583","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G4937329612","display_name":null,"funder_award_id":"HHSN272201100009I","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5702163051","display_name":null,"funder_award_id":"FP7/2007","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5865426078","display_name":null,"funder_award_id":"HHSN272201100012I","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320314178","display_name":"European Federation of Pharmaceutical Industries and Associations","ror":"https://ror.org/00g1x4v36"},{"id":"https://openalex.org/F4320320298","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2589650577.pdf","grobid_xml":"https://content.openalex.org/works/W2589650577.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W611976593","https://openalex.org/W1980082881","https://openalex.org/W2027214692","https://openalex.org/W2029226207","https://openalex.org/W2036357185","https://openalex.org/W2053551193","https://openalex.org/W2054041231","https://openalex.org/W2075803027","https://openalex.org/W2077064436","https://openalex.org/W2081417349","https://openalex.org/W2100773919","https://openalex.org/W2102055645","https://openalex.org/W2103988580","https://openalex.org/W2128149741","https://openalex.org/W2129213376","https://openalex.org/W2129842338","https://openalex.org/W2135537843","https://openalex.org/W2138137816","https://openalex.org/W2138603076","https://openalex.org/W2139516496","https://openalex.org/W2146778078","https://openalex.org/W2157151785","https://openalex.org/W2167787735","https://openalex.org/W2168519960","https://openalex.org/W2169700051","https://openalex.org/W2171713020","https://openalex.org/W2225858423","https://openalex.org/W2227782493","https://openalex.org/W2328586075","https://openalex.org/W2331205791","https://openalex.org/W2332678502","https://openalex.org/W2333152051","https://openalex.org/W2405392974","https://openalex.org/W2409709769","https://openalex.org/W2464074067","https://openalex.org/W2822236128","https://openalex.org/W2950308622","https://openalex.org/W4242318543","https://openalex.org/W4253853981"],"related_works":["https://openalex.org/W2313960855","https://openalex.org/W2099617977","https://openalex.org/W1983079071","https://openalex.org/W1889205290","https://openalex.org/W2620705787","https://openalex.org/W2000640630","https://openalex.org/W4401025306","https://openalex.org/W2160816268","https://openalex.org/W3008030167","https://openalex.org/W3006092675"],"abstract_inverted_index":{"ABSTRACT":[0],"The":[1],"novel":[2],"bacterial":[3],"topoisomerase":[4,18,63],"inhibitor":[5,13],"class":[6],"is":[7],"an":[8],"investigational":[9],"type":[10,44],"of":[11,14,33,38,42,45,57,82,118,122,152,197,237],"antibacterial":[12,136,263],"DNA":[15,60,70,198],"gyrase":[16,61],"and":[17,51,62,84,90,100,112,125,160,185,214,250],"IV":[19,64],"that":[20,174,206],"does":[21],"not":[22,67],"have":[23],"cross-resistance":[24,95],"with":[25,96,150],"the":[26,31,34,54,69,139,168,194,207,233,241],"quinolones.":[27],"Here,":[28],"we":[29],"report":[30],"evaluation":[32],"in":[35,193,201,252],"vitro":[36,202,253],"properties":[37],"a":[39,79,116,187,210],"new":[40],"series":[41,208],"this":[43],"small":[46],"molecule.":[47],"Exemplar":[48],"compounds":[49,133],"selectively":[50],"potently":[52],"inhibited":[53],"catalytic":[55],"activities":[56],"Escherichia":[58],"coli":[59,102,127,159,172],"but":[65],"did":[66],"block":[68],"breakage-reunion":[71],"step.":[72],"Compounds":[73],"showed":[74],"broad-spectrum":[75,262],"inhibitory":[76,224],"activity":[77],"against":[78,115,141,157],"wide":[80],"range":[81],"Gram-positive":[83],"Gram-negative":[85],"pathogens,":[86],"including":[87],"biodefence":[88],"microorganisms":[89],"Mycobacterium":[91],"tuberculosis":[92],".":[93],"No":[94],"fluoroquinolone-resistant":[97],"Staphylococcus":[98],"aureus":[99],"E.":[101,126,158,171],"isolates":[103,121],"was":[104],"observed.":[105],"Measured":[106],"MIC":[107],"90":[108],"values":[109],"were":[110,148,175,180],"4":[111],"8":[113],"\u03bcg/ml":[114],"panel":[117],"contemporary":[119],"multidrug-resistant":[120],"Acinetobacter":[123],"baumannii":[124,162],",":[128],"respectively.":[129],"In":[130,231],"addition,":[131],"representative":[132],"exhibited":[134],"greater":[135],"potency":[137],"than":[138],"quinolones":[140],"obligate":[142],"anaerobic":[143],"species.":[144],"Spontaneous":[145],"mutation":[146],"rates":[147],"low,":[149],"frequencies":[151],"resistance":[153,248],"typically":[154],"<10":[155],"\u22128":[156],"A.":[161],"at":[163],"concentrations":[164],"equivalent":[165],"to":[166,240],"4-fold":[167],"MIC.":[169],"Compound-resistant":[170],"mutants":[173],"isolated":[176],"following":[177],"serial":[178],"passage":[179],"characterized":[181],"by":[182],"whole-genome":[183],"sequencing":[184],"carried":[186],"single":[188],"Arg38Leu":[189],"amino":[190],"acid":[191],"substitution":[192],"GyrA":[195],"subunit":[196],"gyrase.":[199],"Preliminary":[200],"safety":[203,254],"data":[204],"indicate":[205],"shows":[209],"promising":[211],"therapeutic":[212],"index":[213],"potential":[215,246,261],"for":[216,247],"low":[217,245],"human":[218],"ether-a-go-go-related":[219],"gene":[220],"(hERG)":[221],"inhibition":[222],"(50%":[223],"concentration":[225],"[IC":[226],"50":[227],"],":[228],">100":[229],"\u03bcM).":[230],"summary,":[232],"compounds'":[234],"distinct":[235],"mechanism":[236],"action":[238],"relative":[239],"fluoroquinolones,":[242],"whole-cell":[243],"potency,":[244],"development,":[249],"favorable":[251],"profile":[255],"warrant":[256],"their":[257],"continued":[258],"investigation":[259],"as":[260],"agents.":[264]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-03-03T00:00:00"}